A scheme for defining cause of death and its application in the T cell depletion trial

Area of Science:

• Hematology
• Transplantation Medicine
• Clinical Research Methodology

Background:

• Accurate cause of death (COD) determination is crucial in hematopoietic stem cell transplantation (HSCT) studies.
• Existing criteria for COD reporting in HSCT lack sufficient stringency, leading to inconsistent interpretations.
• A randomized multicenter trial of unrelated HSCT identified the need for improved COD assessment.

Purpose of the Study:

• To critically assess and reclassify primary and contributing causes of death (COD) in patients undergoing unrelated hematopoietic stem cell transplantation (HSCT).
• To develop and apply a more stringent algorithm for uniform COD assignment in HSCT.
• To evaluate the impact of the revised criteria on the attribution of specific CODs, such as graft-versus-host disease and infection.

Main Methods:

• A panel of experts reviewed CODs from 281 deceased patients in a randomized multicenter HSCT trial.
• The panel assessed CODs reported using the Center for International Blood and Marrow Transplant Research and National Marrow Donor Program form.
• A hierarchical scheme was developed and applied to reclassify reported CODs, particularly for the T cell depletion project.

Main Results:

• The expert panel reclassified 157 (56%) of the submitted CODs.
• The revised classification led to a significant increase in identifying graft-versus-host disease as the primary COD.
• There was a corresponding decrease in attributing the primary COD to infection following the application of the new scheme.

Conclusions:

• The developed algorithm promotes consistent and uniform assignment of primary and contributing CODs in HSCT.
• This improved methodology is particularly beneficial for patients with leukemia or lymphoma undergoing myeloablative allogeneic HSCT.
• The findings underscore the importance of standardized COD assessment for accurate interpretation of HSCT outcomes.